New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.

Rebecca A Clark Chathika Krishan Weerasuriya Allison Portnoy Christinah Mukandavire Matthew Quaife Roel Bakker Danny Scarponi Rebecca Claire HarrisKirankumar RadeSanjay Kumar MattooDheeraj TumuNicolas A Menzies Richard G White

Published in: medRxiv : the preprint server for health sciences (2023)

and BCG-revaccination could be impactful and cost-effective in India. However, there is great uncertainty in impact, especially with varying vaccine characteristics. Greater investment in vaccine development and delivery is needed to raise the probability of success.

Keyphrases

mental health
healthcare
public health
young adults
mycobacterium tuberculosis
human health
childhood cancer
hiv aids
pulmonary tuberculosis
emergency department
risk assessment
climate change
drug induced